Acamprosate Calcium

阿坎酸钙

Report date: 2026/02/18 20:02:09
NMEFirst In Class

Base Information

Drug NameAcamprosate Calcium
Drug Alias Name乙酰高牛磺酸钙acamprosate阿坎酸AlcomedCampral EC +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticSchizophreniaAutism Spectrum Disorder +[14] 
Global Approved IndicationsAlcoholism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1987/01/01
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Southern CaliforniaNational Institute Of Neurological Disorders And StrokeDresden University Of Technology
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)Oregon Health And Science UniversitySynchroneuron Inc +[9] 
Active IndicationsAlcoholismMotor Neuron DiseaseAmyotrophic Lateral Sclerosis +[4] 
Inactive IndicationsStress Disorders, Post-TraumaticSchizophreniaAutism Spectrum Disorder +[10] 

Other Information

ATC CodeN07BB03
Related LinksWikipediaDrugBankKEGG